Idiopathic Pulmonary Fibrosis

Advances in Diagnostic Tools and Disease Management

Nonfiction, Health & Well Being, Medical, Specialties, Pulmonary & Thoracic, Science & Nature, Science, Biological Sciences, Biochemistry
Cover of the book Idiopathic Pulmonary Fibrosis by , Springer Japan
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9784431555827
Publisher: Springer Japan Publication: September 28, 2015
Imprint: Springer Language: English
Author:
ISBN: 9784431555827
Publisher: Springer Japan
Publication: September 28, 2015
Imprint: Springer
Language: English

From epidemiology and pathogenesis to disease management, this book reviews our current understanding of and provides up-to-date information of Idiopathic Pulmonary Fibrosis (IPF). A subtype of Idiopathic Interstitial Pneumonias (IIP), IPF is one of the most elusive and intractable respiratory disease to date and its triggering factors remain unclear. However, new developments such as serum markers that are highly specific to IPF (i.e. KL-6, SP-A, and SP-D), the establishment of systematic diagnostic imaging (HRCT) and accumulated reports of treatment using an antifibrotic agent (pirfenidone) are slowly improving our understanding of the disease. Edited by an established authority in the field and written by experts, this book will be valuable to not only to beginning learners but also to physicians, instructors and researchers whose work involves IIPs. With each chapter exploring critical questions, with unresolved issues and future prospects, the book offers a valuable resource for understanding issues such as the newly proposed entity of interstitial pneumonia with emphysema (combined pulmonary fibrosis and emphysema: CPFE) and the mechanism of how so many IIP sufferers develop lung cancer.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

From epidemiology and pathogenesis to disease management, this book reviews our current understanding of and provides up-to-date information of Idiopathic Pulmonary Fibrosis (IPF). A subtype of Idiopathic Interstitial Pneumonias (IIP), IPF is one of the most elusive and intractable respiratory disease to date and its triggering factors remain unclear. However, new developments such as serum markers that are highly specific to IPF (i.e. KL-6, SP-A, and SP-D), the establishment of systematic diagnostic imaging (HRCT) and accumulated reports of treatment using an antifibrotic agent (pirfenidone) are slowly improving our understanding of the disease. Edited by an established authority in the field and written by experts, this book will be valuable to not only to beginning learners but also to physicians, instructors and researchers whose work involves IIPs. With each chapter exploring critical questions, with unresolved issues and future prospects, the book offers a valuable resource for understanding issues such as the newly proposed entity of interstitial pneumonia with emphysema (combined pulmonary fibrosis and emphysema: CPFE) and the mechanism of how so many IIP sufferers develop lung cancer.

More books from Springer Japan

Cover of the book Systems Science for Complex Policy Making by
Cover of the book Opera House Acoustics Based on Subjective Preference Theory by
Cover of the book Mathematical Progress in Expressive Image Synthesis II by
Cover of the book Functionalized Redox Systems by
Cover of the book Gastric Anisakiasis in Japan by
Cover of the book Zero-Carbon Energy Kyoto 2010 by
Cover of the book Space-Time Foliation in Quantum Gravity by
Cover of the book Cortical Development by
Cover of the book Fiber Fuse by
Cover of the book Photon-Working Switches by
Cover of the book Blood Flow in the Heart and Large Vessels by
Cover of the book Helicobacter pylori Research by
Cover of the book Indexation and Causation of Financial Markets by
Cover of the book Normally-Off Computing by
Cover of the book Urban Mining Systems by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy